These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Symmetrical drug related intertriginous and flexural exanthema (SDRIFE) induced by fluconazole: An uncommon side effect of a commonly used drug. Kumar S; Bhale G; Brar BK Dermatol Ther; 2019 Nov; 32(6):e13130. PubMed ID: 31659833 [No Abstract] [Full Text] [Related]
25. Symmetrical drug-related intertriginous and flexural exanthema (Baboon syndrome) associated with Infliximab: a case-based review. Keshavamurthy C; Fibeger E; Virata A; Bansal P ARP Rheumatol; 2022; 1(4):322-327. PubMed ID: 36617314 [TBL] [Abstract][Full Text] [Related]
27. Rare case of itraconazole induced SDRIFE (symmetrical drug-related intertriginous and flexural exanthema). Koschitzki K; Karrer S; Berneburg M; Niebel D; Drexler K J Dtsch Dermatol Ges; 2024 Jun; 22(6):833-836. PubMed ID: 38567643 [No Abstract] [Full Text] [Related]
28. Symmetrical drug-related intertriginous and flexural exanthema secondary to topical 5-fluorouracil. Powers R; Gordon R; Roberts K; Kovach R Cutis; 2012 May; 89(5):225-8. PubMed ID: 22768435 [TBL] [Abstract][Full Text] [Related]
29. Co-occurrence of Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) and Pigmented Fixed Drug Eruption (FDE) in a Single Patient Due to Doxycycline: A Case Report. Sahu K; Sirka CS; Pradhan S; Rout AN Indian Dermatol Online J; 2020; 11(1):62-64. PubMed ID: 32055511 [TBL] [Abstract][Full Text] [Related]
30. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by golimumab. Yang SY; Lan CC; Hu SC Int J Dermatol; 2017 May; 56(5):571-572. PubMed ID: 28217835 [No Abstract] [Full Text] [Related]
31. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) after administration of corticosteroids: Case series and review of literature. Steininger J; Bauer A; Hasler H; Beissert S; Abraham S Contact Dermatitis; 2024 Aug; 91(2):146-151. PubMed ID: 38769741 [TBL] [Abstract][Full Text] [Related]
32. Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Caused by Etoricoxib. Caralli ME; Seoane Rodríguez M; Rojas Pérez-Ezquerra P; Pelta Fernández R; De Barrio Fernández M J Investig Allergol Clin Immunol; 2016; 26(2):128-9. PubMed ID: 27164635 [No Abstract] [Full Text] [Related]
33. Rising trends of symmetrical drug related intertriginous and flexural exanthem due to Itraconazole in patients with superficial dermatophytosis: A case series of 12 patients from eastern part of India. Hassanandani T; Panda M; Agarwal A; Das A Dermatol Ther; 2020 Nov; 33(6):e13911. PubMed ID: 32594647 [TBL] [Abstract][Full Text] [Related]
34. Characterization of T-Helper Immune Phenotype in Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE) Endorses a Delayed-Type Hypersensitivity Reaction. Chaudet KM; Russell-Goldman E; Horn TD; Schuler AM; Chan MP; Nazarian RM Am J Dermatopathol; 2024 Feb; 46(2):71-78. PubMed ID: 38133537 [TBL] [Abstract][Full Text] [Related]
36. Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination. Lim PN; Wylie G Clin Exp Dermatol; 2022 Jan; 47(1):175-176. PubMed ID: 34399001 [TBL] [Abstract][Full Text] [Related]
37. Coix lacryma-jobi associated symmetrical drug-related intertriginous and flexural exanthema. Choi MJ; Oh SH; Cho SB Int J Dermatol; 2014 Apr; 53(4):e301-3. PubMed ID: 24261789 [No Abstract] [Full Text] [Related]
38. Symmetrical drug-related intertriginous and flexural exanthema. Tan SC; Tan JW Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):313-8. PubMed ID: 21659857 [TBL] [Abstract][Full Text] [Related]
39. A Case of Intertriginous and Flexural Exanthema caused by Amoxicillin. Cancela-Díez B; López-Delgado D; Aneiros-Fernandez J; Ruiz-Villaverde R Sultan Qaboos Univ Med J; 2019 Nov; 19(4):e369-e371. PubMed ID: 31897322 [TBL] [Abstract][Full Text] [Related]
40. Paracetamol-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient receiving apremilast therapy. Megna M; Cinelli E; Napolitano M; Fabbrocini G; Patruno C Contact Dermatitis; 2019 Dec; 81(6):451-454. PubMed ID: 31328275 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]